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ENDOTOXINS (lipopolysaccharides, LPS) are agents of
pathogenicity of Gram-negative bacteria, implicated in the
development of Gram-negative shock. Endotoxin reacts
with lipopolysaccharide-sensitive cells producing en-
dogenous mediators such as tumour necrosis factor alpha
(TNFt). Macrophages are cells mediating the toxic
activities of LPS and TNFt is the primary mediator of the
lethal action of endotoxin. This review article discusses the
various mechanisms by which endotoxin hypersensitivity
in bacteria-sensitized animals develops. The paper con-
cludes with a discussion on the possible protective effect
of carnitine congeners against the lethal action of LPS.
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Introduction
Endotoxins are constituents of the outer
membrane of Gram-negative bacteria. Isolated
endotoxin administered into experimental animals
elicits a large spectrum of biological activities which
are also manifested during Gram-negative septic
shock.
Endotoxins are lipopolysaccharides (LPS). In
Enterobacteriaceae and in many cases of other
Gram-negative bacteria, LPS are found to consist
of three covalently linked regions, the lipid A, the
core oligosaccharide and the O-specific poly-
saccharide. The structure and composition of the
O-polysaccharide is highly variable among Gram-
negative bacteria, determining the serological
specificity of the parent bacterial strain. The core
oligosaccharide is less variable in its structure and
composition, a given core structure being common
to large groups of bacteria. Lipid A is structurally
the least variable part of the LPS molecule,
exhibiting a similar structure and composition
among many Gram-negative bacteria (for reviews
see References 1-3). All three parts of the LPS
molecule are immunogenic, eliciting the formation
of antibodies interacting specifically with distinct
epitopes in the respective region. The biological
activity of LPS resides solely in the lipid A, the
polysaccharide being devoid of toxic activity.
2
Table i summarizes the large spectrum of biological
activities that were found to be expressed by
purified LPS or isolated free lipid A. As seen from
the table the activities of endotoxin are not always
harmful but some of these, such as induction of
tumour necrosis and adjuvant activity, can be
beneficial to the host.
The biological activities of LPS are not direct
effects of the LPS molecule but are induced
indirectly by endogenous mediators that are
produced following interaction of endotoxin with
Table 1. Biological activities of lipopolysaccharides and free lipid A
Pyrogenicity
Lethal toxicity in mice
Leucopenia
Leucocytosis
Local Shwartzman reaction
Bone marrow necrosis
Embryonic bone resorption
Complement activation
Depression of blood pressure
Platelet aggregation
Hageman factor activation
Induction of plasminogen activator
Limulus lysate gelation
Toxicity enhanced by growing tumours
Toxicity enhanced by BCG, P. acnes
Toxicity enhanced by Gram-negative infection
Toxicity enhanced by adrenalectomy
Toxicity enhanced by g-galactosamine
Enhanced dermal reactivity to noradrenaline
Induction of nonspecific resistance to infection
Induction of tolerance to endotoxin
Induction of early refractory state to temperature change
Adjuvant activity
Mitogenic activity for cells
Tumour necrotic activity
Macrophage activation
Induction of colony stimulating factor
Induction of IgG synthesis in newborn mice
Induction of protaglandin synthesis
Induction of interferon production
Induction of tumour-necrotizing factor and other cytokines
Induction of mouse liver pyruvate kinase
Type C RNA virus release from mouse spleen cells
Helper activity for Friend spleen focus-forming virus in mice
Inhibition of phosphoenolpyruvate carboxykinase
Hypothermia in mice
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LPS-sensitive cells. Macrophages are cells mediating
the toxic activities of LPS
*6 and turnout necrosis
factor alpha (TNF) is a primary mediator of the
lethal action of endotoxin.
7--1
The activity of endotoxin may be influenced
(enhanced or suppressed) by a number of plasma
proteins of the host, which are capable of binding
LPS. These include high and low density
lipoproteins (HDL and LDL),
11---14 LPS-binding
protein (LBP)
lb and, in addition, specific antibodies
directed against the LPS serotype in question and
which may be present in the individual host. In the
case of endotoxin shock resulting from infection,
the toxic activity of the LPS released from the
infecting micro-organism may be influenced addi-
tionally by bacterial proteins (e.g. Omp A) with
which the released LPS may be associated.
16
Sensitivity to endotoxin is genetically de-
termined, rabbits, swine and humans being highly
sensitive; while mice, rats or guinea-pigs are, in
comparison, much less sensitive. Mice, depending
on strain, usually succumb to the lethal activity of
200--400 #g of LPS. Endotoxin-resistant strains of
mice have been identified which are insensitive to
all LPS effects.7’8 These are usually referred to as
LPS nonresponders and are designated as lpsC, in
contrast to mice with normal sensitivity (LPS
responder) which are designated as lps. The high
resistance of lps
d mice is due to a genetic defect in
the LPS gene locus present on chromosome 4.18
Table 2. Induction of hypersensitivity to endotoxin treatment
Condition which increases
endotoxin hypersensitivity Sensitization factor
Microbial infections
Gram-negative
Salmonella
E. Coli
Klebsiella
Coxiella burnetii
Gram-positive
Propionibacterium acnes
BCG
Bacterial products
Proteins
MDP
Parasitic infections
100-> 000
50
100
Malaria B. chabaudi chabaudO > O0
Growing tumours
Lewis lung carcinoma > 10 000
EMT6 sarcoma 200
Hepatotoxic agents
g-galactosamine 100 000
-amanitine > 000
Other agents
Carbon tetrachloride > 000
Lead acetate > 000
Actinomycin-D > 10 000
Hyperthermia
Environmental temperature 30-33C > 000
Cortisone deficiency
Adrenalectomy > 000
Hypophysectomy > 000
Table 3. Hypersensitivity of LLC and EMT6 tumour bearing
mice to LPS or recombinant TNF
Endotoxin hypersensitivity
_Although sensitivity to endotoxin is genetically
determined it has been known for many years that
the sensitivity of normal healthy animals may be
considerably increased under different experimental
conditions. The most important of these are listed
in Table 2. Thus treatment of experimental animals
with hepatotoxic agents such as D-galactosamine
will increase their sensitivity to the lethal effects of
endotoxin more than 100000-fold. A significant
degree of sensitization may also be achieved
following treatment of mice with muramyl dipep-
tide (MDP), a partial structure of peptidoglycan.
Further, adrenalectomy hypophysectomy or expo-
sure to a hyperthermic environment will all
enhance considerably the sensitivity to endotoxin.
9
The sensitivity of mice to endotoxin was also
found to be increased by a number of growing
tumours. Thus Lewis lung carcinoma, and the
EMT6 sarcoma growing in C57BL/6 and BALB/C
mice, respectively, were shown to increase
considerably the endotoxin sensitivity of the
animals2 (Table 3).
Sensitization to endotoxin also proceeds follow-
ing treatment with live (infection) or killed
bacteria.21’22 Both Gram-positive
23 and Gram-
LD5o(/g/mouse)
Mice LPS LPS
Normal C57BL6 400 300
C57BL with carcinoma 0.1 0.01
(15 day tumour)
Normal Balb/c 300 300
Balb/c with sarcoma 2 4
(15 day tumour)
Female C57BL/6 and Balb/c mice were inoculated respec-
tively with 3LL cells intramuscularly or EMT6 cells subcutan-
eously. Fifteen days later the animals were challenged
intraperitoneally with increasing doses of recombinant TNF or
Salmonella a. equi LPS. Each group was formed of six animals
receiving increasing doses of the test compound. The mortality
was recorded during 48 h.
negative micro-organisms were shown to increase
the susceptibility of mice to the lethal activity of
endotoxin. Sensitization by bacteria is of special
interest and is dealt with in more detail in the
following section.
Bacteria-induced hypersensitivity to
endotoxin
For the induction of hypersensitivity to LPS by
bacteria both live or killed micro-organisms may be
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500
TNF (U/ml) Table 4. Sensitivity of mice pretreated with different bacteria to
the lethal effects of LPS
400
Pre-treatment Approx. LD5o(#g LPS)
Mice
HeN Sn
300
200
100
none 400 100
P. acnes 0.2 0.1
C. burnetii 2 0.5
S. typhimurium 3 3
Table 5. Enhanced production of TNF by LPS in C57BL/10
ScSn mice treated with bacteria
Treatment (ng/ml)
0 2 3 4 5 6
Time after infection (days)
FIG. 1. Enhanced production of TNF by LPS in C3H/HeN mice infected
with S. Typhimurium. Mice were infected with 50 CFU S. typhimurium
and challenged with 10 #g LPS. Plasma was collected 60 min after LPS
administration.
used. Considerable changes in sensitivity of
C57BL/6 mice to the lethal activity of LPS
following infection with a lethal inoculum of
Salmonella typhimurium have been demonstrated.
24
Thus, before infection, a dose of over 200 #g
endotoxin was required to kill the animals. After
infection, sensitivity increased daily in an almost
logarithmic pattern and by day 5 after infection the
24 lethal dose of endotoxin was less than 1 #g.
Sensitization to LPS may be also achieved by
sub-lethal infection as shown in Fig. 1.
22 Mice
(C3H/Tif), infected with a sublethal inoculum of S.
thyphimurium exhibit enhanced sensitivity to en-
dotoxin. Sensitization becomes evident on day 2
after infection, reaches a maximum on days 7 to 8
and decreases again reaching normal levels several
weeks later. Fig. 1 also shows that sensitization to
LPS by sublethal infection is at the same time a
sensitization to TNF0.
Mechanisms of endotoxin
hypersensitivity induced by bacteria
The property of bacteria to enhance endotoxin
sensitivity is not confined to S. typhimurium, but is
a general phenomenon observed with dierent live
or killed Gram-negative and Gram-positive bac-
teria. An example of this is shown in Table 4.
Mice made hypersensitive to the lethal eects of
I,PS by bacteria are found, on LPS challenge, to
produce considerably more TNF0 than do normal
animals.
25 This is shown in Table 5 where it can be
seen that treatment of mice with Propionibacterium
aches or S. typhimurium leads, on LPS challenge, to
none none n.d.
10 2.1
P. acnes none n.d.
10 3 000
S. typhimurium none n.d.
10 454
Mice were treated with P. acnes (500#g, 7 days before
challenge) I.V. or S. typhimurium (50CFU, 3days before
challenge) i.p., and challenged with LPS i.v. Serum for TNF
assay was collected h after challenge. TNF was measured by
the 929 cell cytotoxicity assay with murine rTNF as standard.
n.d. not detectable
a 1 500- and 200-fold increase in the amount of
TNF produced, respectively (Fig. 2).
Since TNF is a primary mediator of the lethal
activity of LPS, the overproduction of TNF0 by
LDso (#g)
100
10-
0.1
0 5 10 15 20 25 30
Days after infection
FIG. 2. Sensitization of mice to the lethal activity of LPS and HrTNF by
sub-lethal infection with S. typhimurium. Mice (C3H/Tif) were infected
with 2 104 CFU of S. typhimurium and on different days thereafter
groups were challenged with different amounts of LPS and the LDso
values were calculated. LPS, 0 HrTNF.
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Table 6. Effect of treatment with bacteria on the sensitivity of
mice to the lethal activity of human rTNF
Lethality
Treatment %
none 75 0
225 50
P. acnes 0
5 20
10 100
S. typhimurium 10
10 100
that IFN2 is the mediator of sensitization of animals
treated with bacteria to the lethal activity of LPS.
2s
Thus, administration of anti-IFNy monoclonal
antibodies to mice pre-treated with bacteria
inhibited the overproduction of TNF0 (Fig. 3) and
abolished the development of sensitization to the
lethal activity of LPS (Table 7).
6000
C57BL/10 ScSn mice were treated with heat killed P. acnes
(500/g i.v., 7 days before challenge), or infected with S.
typhimurium (50 CFU i.p., 3 days before challenge). Human
TNF was administered i.v.
LPS, in bacteria sensitized animals, would alone
explain hypersensitivity. However, the high endo-
toxin sensitivity of bacteria treated mice is not
due only to an overproduction of TNF0. Mice
sensitized to the lethal effects of LPS by bacteria are
also found to be hypersensitive to the lethal activity
of TNF0. This is shown in Table 6. Therefore the
hypersensitivity to the lethal effects of endotoxin
seen in bacteria sensitized mice is based on (a) an
overproduction of TNF0, and (b) a higher
sensitivity to the lethal effects of TNF.
The induction of hypersensitivity by Gram-
negative bacteria is of special interest since these
micro-organisms also produce endotoxin. The
present results make it evident that Gram-negative
bacteria not only produce endotoxin but also
sensitize the infected organism to its toxic action,
and therefore enable a better understanding of the
hazardous consequences of Gram-negative in-
fections.
Mechanism of the sensitization to
endotoxin by bacteria
Interferon gamma, a mediator of the bacteria-induced
sensitization: Very recently a breakthrough in the
understanding of the mechanism by which bacteria
sensitize the organism to endotoxin was achieved.
When mice are infected with live, or treated with
killed, Gram-negative or Gram-positive bacteria,
they are found to contain in their serum significant
amounts of interferon gamma (IFN).
2s The
production of IFN2 following treatment with
bacteria is true for all strains of mice that are
sensitive to endotoxin. The observation was made
however that a similar treatment of LPS resistant
(lpsd) strains of mice (see introduction) with bacteria
does not lead to IFNy production.
26 This
observation suggested that the inability of lps
d mice
to be sensitized by bacteria might be due to their
inability to produce IFNy. This possibilit} was
investigated closely, and evidence could be obtained
sooo-
4000
3000
2000
1000
300
20
LPS P. acnes
LPS
P. acnes P. acnes
anti-IFN? anti-|FN
(4 x 100U) (,x 300U)
LPs LPS
FIG. 3. Effect of anti-IFN on P. acnes induced sensitization to LPS. TNF
production.
Table 7. Effect of IFN2 antibodies on the P. acnes induced
sensitization to LPS lethality
Lethality (dead/total)
LPS (/g) Controls P. acnes + IgG P. acnes+ mAb
100 5/5
75 1/5
50 0/10 6/10
25 0/5
5/5
0.1 2/5
0.01 0/5
C57BL/10 ScSN mice received 500 lg P. acnes, i.v. Thereafter,
one group of mice received 4 x 300 #g (300 U) anti-IFNT, a
second group 4 x 300 #g control IgG i.p. on days 0, 2, 4 and
6 after P. acnes treatment. Seven days after P. acnes,
all mice were challenged with LPS, i.v. Normal, untreated Sn
mice, injected with LPS only served as controls. Lethality was
scored up to 72 h after LPS injection.
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Protection against endotoxin shock
Even since LPS was recognized as the main toxic
component of Gram-negative bacteria, research
groups all over the world have been searching for
eective ways for treating and preventing en-
dotoxin shock. One approach investigated extens-
ively has been the use of antibodies to different
regions of the LPS molecule. Of special interest
have been antibodies directed towards parts of the
LPS molecule that are common among clinically
relevant Gram-negative micro-organisms. Other
approaches include the use of cortisone, antibodies
to the LPS receptor and the use of LPS receptor
antagonists.
Recently, the authors investigated whether
carnitine congeners might exhibit a protective effect
against the lethal action of LPS. In these
experiments both -carnitine and acetyl4-carnitine
were used. The lethality models used include mice
sensitized to the lethal activity of LPS by D-GaIN
and by Propionibacterium acnes, as well as normal
mice. In approximately 50% of the experiments a
protection was seen in both sensitization models.
Even where no protection was found in terms of
survival, a prolongation of survival was always
evident. The following tables show the results of
typical experiments in which protection was found.
Table 8 shows that administration of 5 mg
acetyl--carnitine/mouse, 30 min prior to a lethal
challenge with LPS and D-GaIN afforded complete
protection to the animals. A similar protection was
seen when instead of LPS, recombinant hTNF0 and
D-GaIN were used for challenge (Table 9). An
investigation of the time of acetyl--carnitine
administration that yields optimal protection
Table 10. Effect of time of acetyI-L-carnitine injection on the
lethal activity of LPS/GalN in mice
Time of Ac-L-carnitine Time of LPS/GalN Lethality
administration (h) injection (h) deal/total
-24 0 1/4
-4 0 2/4
-2 0 0/4
0 0 1/4
0 2/4
4 0 4/4
C57BL/6 mice received acetyI-L-carnitine (5 mg) at the times
indicated, and D-GaIN (20 mg) with LPS (0.002 #g) at 0 h.
Table 11. Effect of acetyI-L-carnitine on the lethal activity of
LPS in P. acnes sensitized mice
Ac- L-carn itine LPS Lethal ity
(mg) (mg) dead/total
10 0.2 1/4
5 0.2 0/4
2.5 0.2 0/4
1.25 0.2 3/4
0.2 4/4
(C57BL/6) mice were treated with 500 #g killed Propioni-
bacterium acnes i.v. 7 days before challenge. Acetyl-L-carnitine
was administered i.p. h before LPS (i.v.).
revealed that the drug afforded maximum protec-
tion when administered 1-2 h before LPS/GalN
challenge (Table 10). A protection by acetyl4-
carnitine was also seen in mice sensitized by P. acnes
and challenged with LPS (Table 11). More
experiments are being carried out in order to
confirm the protection seen so far and to make a
preliminary identification of the possible mech-
anisms involved.
Table 8. Effect of acetyI-L-carnitine on the lethal activity of LPS
in D-GaIN sensitized mice
Ac-L-carnitine D-GaIN LPS Lethality
(mg) (mg) (#g) dead/total
5 20 0.002 0/4
20 0.002 4/4
Mice were C57B’L/6 strain; LPS was from S. abortus equi;
all injections were administered i.v.; acetyl-L-carnitine was
administered 30 min prior to LPS/D-GalN
Table 9. Effect of acetyI-L-carnitine on the lethal activity of
TNF# in D-GaIN sensitized mice
Ac-L-carnitine D-GaIN TNF Lethality
(mg) (mg) (#g) dead/total
5 20 0/4
20 4/4
Mice were C57BL/6 strain; LPS was from S. abortus equi; all
injections were administered i.v." acetyl-L-carnitine was admin-
istered 30 min prior to LPS/D-GalN
References
1. Liideritz O, Galanos C, Lehman V, Mayer H, Rietschel E Th, Weckesser J.
Chemical structure and biological activities of lipid A’s from various bacterial
families. Naturwissenschaften 1978; 65: 579-585.
2. Galanos C, Liideritz O, Rietschel E Th, Westphal O. Newer aspects of the
chemistry and biology of bacterial lipopolysaccharides, with special reference
to their lipid A component. In: Goodwin TW, ed. International Review of
Biochemistry, Vol. 14, Biochemistry of Lipids II, Baltimore: University Park
Press, 239-335.
3. Rietschel E Th, ed. Handbook of Endotoxin, Vol. 1, Chemistry of Endotoxin.
Elsevier, 1984.
4. Michalek SM, Moore RN, McGhee JR, Rosenstreich DL, Mergenhagen SE.
The primary role of lymphoreticular cells in the mediation of host responses
to bacterial endotoxin. J Infect Dis 1980; 141: 55-63.
5. Rosenstreich DL, Vogel SN. Central role of macrophages in the host
response to endotoxin. In: Schlesinger D, ed. Microbiolog--1980.
Washington, D.C. American Society for Microbiology, 1980; 11-15.
6. Freudenberg MA, Keppler D, Galanos C. Requirement for lipopolysacchar-
ide-responsive macrophages in galactosamine-induced sensitization to
endotoxin. Infect Immun 1986; 51: 891-895.
7. Beutler B, Milsark JW, Cerami AC. Passive immunization against
cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
Science 1985; 229: 869-871.
8. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysacchar-
ide and turnout necrosis factor in normal and D-galactosamine-treated mice.
J Exp Med 1987; 165 657-663.
9. Galanos C, Freudenberg MA, Coumbos A, Matsuura M, Lehmann V,
Bartoleyns J. Induction of lethality and tolerance by endotoxin mediated
by macrophages through tumour necrosis factor. In: Bonavida B, Gifford
GE, Kirchner H, Old LJ, eds. Turnout Necrosis Factor/Cachectin and Related
Cytokines. Basel: S. Karger, 1988: 114-127.
Mediators of Inflammation. Vol 2 (Supplement). 1993 $15C. Galanos and M.A. Freudenberg
10. Freudenberg MA, Galanos C. Tumour necrosis factor alpha mediates lethal
activity of killed gram-negative and gram-positive bacteria in
galactosamine-treated mice. Infect Immun 1991 59:2110-2115.
11. Skarnes RC. In: Berry LJ, ed. Cellular Biology of Hndotoxin, VoL 3.
Amsterdam, New York, Oxford: Elsevier, 1985; 56.
12. Ulevitch RJ, Johnston AR, Weinstein DB. New function for high density
lipoproteins. Their participation in intravascular reactions of bacterial
lipopolysaccharides. J Clin Invest 1979; 64: 1516-1524.
13. Freudenberg MA, Beg-Hansen TC, Back U, Jirillo E, Galanos C.
Interaction of lipopolysaccharides with plasma high density lipoprotein in
rats. In: Eaker D, Wadstrom T, eds. Natural toxins. New York: Pergamon
Press, 1980.
14. Munford RS, Hall CL, Lipton JM, Dietschy JM. Biological activity,
lipoprotein-binding behaviour, and in vivo disposition of extracted and active
forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 1982; 70:
877-888.
15. Schuhmann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison
JC. Structure and function of lipopolysaccharide-binding protein. Science
1990; 249: 1429--1431.
16. Freudenberg MA, Meier-Dieter U, Staehelin T, Galanos C. Analysis of LPS
released from Salmonella abortus equi in human Microb Pathogen 1991;
10: 93-104.
17. Sultzer BM, Goodman GW. Characteristics of endotoxin-resistant
low-responder mice. In: Schlesinger D, ed. Microbiology---1977, Washington
DC: American Society for Microbiology, 1977: 304--309.
18. Coutinho A, Meo T. Genetic basis for unresponsiveness to lipopolysacchar-
ide in C57BI,/10Cr mice. Immunogenetics 1978; 7: 17-24.
19. Galanos C, Freudenberg MA, Katschinski T, Salomo R, Mossmann H,
Kumazawa Y. Tumour necrosis factor and host response to endotoxin. In:
Ryan J, Morrison DC, eds. Bacterial endotoxin lipopo#saccharides, VoL 2.
Immunopharmacology and pathophysiology. Boca-Raton, FI.: CRC Press Inc.,
1992; 75-104.
20. Bartoleyns J, Freudenberg MA, Galanos C. Growing tumours induce
hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun 1987;
55: 2230-2233.
21. Galanos C, Freudenberg MA, Matsuura M. Mechanisms of the lethal action
of endotoxin hypersensitivity. In: Friedman H, Klein TW, Nakano M,
Nowotny A, eds. Endotoxin A dvances in experimental medicine and biology, VoL
256. New York: Plenum Press, 1990; 603-619.
22. Matsuura M, Galanos C. Induction of hypersensitivity to endotoxin and
tumour necrosis factor by sublethal infection with Salmonella typhimurium.
Infect Immun 1990; 58: 935-937.
23. Suter E, Ullman GE, Hoffmann RG. Sensitivity of mice to endotoxin after
vaccination with BCG (bacillus Calmette-Gurin). Proc Soc Exp Biol Med
1958; 99: 167-169.
24. Galanos C, Freudenberg MA, Krajewska D, Takada H, Georgiev G,
Bartoleyns J. Hypersensitivity to endotoxin. EOS J Immunol Immunopharmacol
1986; 6(Suppl. 3): 78-81.
25. Katschinski T, Galanos C, Coumbos A, Freudenberg MA. Gamma interferon
mediates Propionibacterium acnes-induced hypersensitivity to lipopolysacchar-
ide in mice. Infect Immun 1992; 60: 1994--2001.
26. Freudenberg MA, Kumazawa Y, Meding S, Langhorne J, Galanos C.
Gamma interferon production in endotoxin-responder and -nonresponder
mice during infection. Infect Immun 1991; 59: 3484-3491.
$16 Mediators of Inflammation. Vol 2 (Supplement) 1993